Expert Video - When should genetic testing for MDS be done?
Valeria Santini, MD, an expert on MDS from the University of Florence, describes karyotype analysis (cytogenetic testing) done when MDS is suspected, as well as how often it should be repeated. Testing for gene mutations and cytogenetic alterations is important throughout the course of treatment as a key to prognosis and targeted therapy.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.